Precision360

Precision360™ is ConcertAI's enterprise-grade real-world data environment purpose-built for life sciences discovery in oncology. By integrating the detail and nuance of electronic medical records (EMR) and genomic test data with the breadth and scale of claims data, it delivers a multi-modal, deeply curated dataset that enables researchers to explore hypotheses, model disease burden, and validate endpoints faster than ever before.

Built on the industry's largest oncology dataset, Precision360™ covers data on 9 million patients across 900 sites of care, spanning 48 states and sourced from multiple EHR systems. Its AI-powered curation ensures data recency of under one week, eliminating the delays associated with traditional quarterly update cycles. The platform is designed for self-service exploration, cohort building, and scientific generation, making it suitable for research teams across the life sciences spectrum.

Key Benefits

• Fast: AI-curation delivers data updates in under 7 days, with recency of under a week — no more waiting for quarterly refreshes.
• Broad: Covers 9 million patients across 900 sites of care, with representation across all care setting types, 48 states, and multiple EHR systems.
• Representative: Enables exact matching to inclusion/exclusion criteria or label populations, with tailored cuts by diagnosis, treatment, biomarker expression, and more.
• Insightful: EHR and genomics data is matched and integrated with open claims data and social determinants of health (SDoH), and is available in Precision Suite cross-referenced with site data and publications.

Core Capabilities

• Multi-modal data environment: Structured EMR with 200+ variables across 9 million+ patients, integrated claims and SDoH data for complete patient context, and genomics, biomarker, lab, and imaging integration — supporting both research-grade and hypothesis-driven research.
• Interoperability and governance readiness: HIPAA compliant and de-identified by expert determination, compatible with enterprise data science tools, and supports rapid onboarding through an analysis-ready data structure.

Discovery Use Cases

• Epidemiology analysis: Uncover incidence, prevalence, and demographic trends across disease areas.
• Burden of illness studies: Explore comorbidities, therapy costs, and healthcare utilization patterns across patient segments.
• Natural history modeling: Track patients from diagnosis through multiple lines of therapy to understand real-world disease progression.
• Biomarker stratification: Gain insights into testing rates, mutation presence, and downstream treatment behaviors.
• Endpoint validation: Align real-world outcomes to clinical trial endpoints, supporting the use of real-world data (RWD) in regulatory submission packages.

Precision360™ is part of ConcertAI's broader Precision Suite ecosystem and is designed to integrate seamlessly with enterprise data science tools. The platform adheres to HIPAA compliance standards with expert-determination de-identification, making it suitable for regulated life sciences environments. It is complemented by ConcertAI's CARAai multi-LLM and agentic AI capabilities, further extending its value for clinical development and oncology-specific data extraction challenges.